Discover what’s new with CathWorks and the CathWorks FFRangio™ System.

News

Stay up-to-date on what‘s new.

Mar 04, 2019

CathWorks Appoints Chief Financial Officer

CathWorks announced that Mike Feher has joined CathWorks as Vice President of Finance and Chief Financial Officer. His appointment coincides with US commercialization of the CathWorks FFRangio™ System.

READ MORE

Feb 25, 2019

CathWorks Adds Vice President of Global Marketing to Leadership Team

CathWorks announced that Ramin Mousavi has joined as Vice President of Global Marketing & Strategy to take responsibility for the CathWorks FFRangio™ System U.S. clinical and commercial launch and direct future expansion into other global markets.

READ MORE

Feb 04, 2019

CathWorks Announces Completion Of $30 Million Financing

CathWorks announced the completion of a $30 million Series C financing round led by Deerfield Management.

READ MORE

Dec 27, 2018

CathWorks Names Paul Kapsner as Vice President of Sales

CathWorks announced that Paul Kapsner has been named as Global Vice President of Sales. His appointment coincides with recent United States FDA clearance of the company’s CathWorks FFRangio™ System.

READ MORE

Dec 20, 2018

CathWorks FFRangio™ System Receives U.S. FDA Clearance.

CathWorks announced today that its FFRangio™ System received United States Food & Drug Administration (FDA) 510(k) clearance. The FFRangio system demonstrated accuracy versus the invasive FFR wire in a blinded comparative study, FAST-FFR.

READ MORE

Sep 24, 2018

CathWorks FFRangio™ Trial Meets Primary Enpoint and Exceeds Performance Goals.

The journal Circulation published results from the CathWorks FFRangio™ FAST-FFR clinical trial in an article titled Accuracy of Fractional Flow Reserve Derived From Coronary Angiography.

READ MORE

Sep 12, 2018

CathWorks FFRangio™ System Clinical Review Featured in TCT 2018 Program.

The CathWorks FFRangio™ System will be featured in a TCT Lunch Presentation Theater Program held during the 2018 TCT (Transcatheter Cardiovascular Therapeutics) annual meeting in San Diego.

READ MORE

Aug 29, 2018

FAST-FFR Pivotal Trial Added To TCT 2018 Late-Breaking Clinical Trial Program.

CathWorks announced that the FAST-FFR pivotal trial has been added to the late-breaking clinical science program during the 2018 TCT (Transcatheter Cardiovascular Therapeutics) annual meeting in San Diego.

READ MORE

Aug 22, 2018

CathWorks FFRangio™ System files FDA 510(k) submission.

CathWorks announced that it has submitted its CathWorks FFRangio™ System to the United States Food & Drug Administration (FDA) for review and 510(k) market clearance.

READ MORE

Aug 15, 2018

CathWorks Fast-FFR trial enrollment completed early.

CathWorks announced that its FAST-FFR trial is fully enrolled ahead of schedule. The trial is designed to evaluate efficacy of the CathWorks FFRangio™ System in terms of sensitivity and specificity when compared to conventional invasive Fractional Flow Reserve (FFR).

READ MORE

Events

Come and meet the CathWorks team at our various events and learn how the CathWorks FFRangio™ System can help you and your patients.

Sep 24, 2018 – San Diego, CA

TCT 2018

Lunch Presentation Theater Program

FFRangio for PCI Guidance:
A Clinical Review

READ MORE